Skip to main navigation menu Skip to main content Skip to site footer
FrancoAngeli Journals

Saggi, Studi e Ricerche

No. 48 (2016)

Panic disorder: nosographic entity and clinical disorder

Submitted
maggio 17, 2017
Published
2017-07-05

Abstract

Panic Disorder has not always been recognised as an exclusively psychiatric condition. Research in this area continued along medical and psychological axes until 1980, when the development of Diagnostic and Statistical Manual (DSM)-III criteria established the overall concept of panic disorder. This article briefly synthetizes the history of panic disorder until its current wording according to DSM-5 and provides elements of differential diagnosis with Panic Attacks, Agoraphobia andSubstance-Related and Addicitive Dosorders. The authors present a general framework for understanding the role of cognitions, emotions and physical symptoms in the pathogenesis of Panic Disorder. Recommendations for appropriate pharmacotherapy are also discussed.

References

  1. American Psychiatric Association (APA) (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). Washington DC: American Psychiatric Press.
  2. American Psychiatric Association (APA) (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington DC: American Psychiatric Press.
  3. American Psychiatric Association (APA) (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). Washington DC: American Psychiatric Press.
  4. American Psychiatric Association (APA) (2013). Manuale Diagnostico e Statistico dei Disturbi Mentali, quinta edizione (DSM-5). Milano: Raffaello Cortina Editore.
  5. American Psychiatric Association (APA) (2009). Practice Guideline for the Treatment of Patients With Panic Disorder, 2nd edition. Washington (DC): American Psychiatric Publishing Inc.
  6. Andersch S., Hetta J. A. (2003). 15-year follow-up study of patients with panic disorder. Eur Psychiatry, 18: 401-408.
  7. Baldwin D.S., Talat B. (2012). Should benzodiazepines still have a role in treating patients with anxiety disorders? Hum Psychopharmacol Clin Exp., 27: 237-238.
  8. Baldwin D.S., Aitchison K., Bateson A., Curran H.V., Davies S., Leonard B., Nutt D.J., Stephens D.N., Wilson S. (2013). Benzodiazepines: risks and benefits. A reconsideration. J. Psychopharmacol., 27(11): 967-971.
  9. Baldwin D.S., Anderson I.M., Nutt D.J., Allgulander C., Bandelow B., den Boer J.A., Christmas D.M., Davies S., Fineberg N., Lidbetter N., Malizia A., McCrone P., Nabarro D., O’Neill C., Scott J., van der Wee N., Wittchen H.U. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessivecompulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol, 28(5): 403-439.
  10. Bakhshaie J., Zvolensky M.J., Goodwin R.D. (2016). Cigarette smoking and the onset and persistence of panic attacks during mid-adulthood in the United States: 1994-2005. J Clin Psychiatry, 77(1): 21-24.
  11. Bandelow B., Michaelis S. (2015). Epidemiology of childhood separation anxiety, sensitivity to CO(2), panic disorder, and the effect of childhood parental loss. Arch Gen Psychiatry, 66(1): 64-71.
  12. Battaglia M., Ogliari A., D’Amato F., Kinkead R. (2014). Early-life risk factors for panic and separation anxiety disorder: insights and outstanding questions arising from human and animal studies of CO2 sensitivity. Neurosci Biobehav Rev, 46(3): 455-464.
  13. Biederman J., Petty C., Faraone S.V., Hirshfeld-Becker D.R., Henin A., Rauf A., Scott M., Pollack M., Rosenbaum J.F. (2005). Childhood antecedents to panic disorder in referred and nonreferred adults. J Child Adolesc Psychopharmacol, 15(4): 549-561.
  14. Bienvenu O.J., Onyike C.U., Stein M.B., Chen L.S., Samuels J., Nestadt G., Eaton W.W. (2006). Agoraphobia in adults: incidence and longitudinal relationship with panic. Br J Psychiatry, 188: 432-438.
  15. Bing E.G., Burnam M., Longshore D. et al. (2001). Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus-Infected Adults in the United States. Arch Gen Psychiatry, 58(8): 721-728.
  16. Bowers M.E., Choi D.C., Ressler K.J. (2012). Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide. J. Physiol Behav, 107(5): 699-710.
  17. Bowlby J. (1973). Attachment and loss. Vol. 2 Separation (1st ed), London: Hogarth Press (1980) (2nd ed). New York: Basic Books.
  18. Bowlby J. (1989). Una base sicura. Applicazioni cliniche della teoria dell’attaccamento. Trad. Magnino M., Collana Psicologia clinica e psicoterapia n. 26. Milano: Raffaello Cortina.
  19. Buhler K.E. (2005). Euphoria, ecstasy, inebriation, abuse, dependence, and addiction: a conceptual analysis. Med Health Care Phil, 8: 79-87.
  20. Busch F.N., Milrod B.L., Singer M.B., Aronson A.C. (2011). Manual of Panic Focused Psychodynamic Psychotherapy: extended Range. New York: Routledge.
  21. Busch F.N., Sandberg L.S. (2014). Unmentalized aspects of panic and anxiety disorders. Psychodyn Psychiatry, 42(2): 175-195.
  22. Carta M.G., Hardoy M.C., Garofalo A., Pisano E., Nonnoi V., Intilla G., Serra G., Balestrieri C., Chessa L., Cauli C., Lai M.E., Farci P. (2007). Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health, 23(3): 22.
  23. Chou K.L., Liang K., Mackenzie C.S. (2011). Binge drinking and Axis I psychiatric disorders in community-dwelling middle-aged and older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry, 72: 640-647.
  24. Clark D.M. (1986). A cognitive approach to panic. Behav Res Ther, 24: 461-
  26. Clark D.M. (1988). A cognitive model of panic attacks. In: Rachman S., Moser J.D. (Eds.). Panic: Psychological perspectives (pp. 71-89). Hillsdale, NJ: Erlbaum.
  27. Clark D.M., Salkovskis P.M., Ost L.G., Breitholtz E., Koehler K.A., Westling B.E., Jeavons A., Gelder M. (1997). Misinterpretation of body sensations in panic disorder. J Consult Clin Psychol, 65(2): 203-213.
  28. Cook J.M., Marshall R., Masci C., Coyne J.C. (2007). Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med, 22(3): 303-307.
  29. Curran H.V., Collins R., Fletcher S., Kee S.C.Y., Woods B., Iliffe S. (2003). Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med, 33: 1223-1227
  30. DaCosta J.M. (1871). On irritable heart: a clinical study of a functional cardiac
  31. disorder and its consequences. Am J Medical Sciences, 61: 17-52.
  32. De Berardis D., Campanella D., Gambi F., La Rovere R., Sepede G., Core L., Canfora G., Santilli E., Valchera A., Mancini E., Salerno R.M., Moschetta F.S., Ferro F.M. (2007). Alexithymia, fear of bodily sensations, and somatosensory amplification in young outpatients with panic disorder. Psychosomatics, 48(3): 239-246.
  33. Doble A., Martin I. (2000). Insights into the mechanisms of benzodiazepine
  34. dependence. Eur Neuropsychopharmacol, 10: 169-169.
  35. Ehlers A., Breuer P. (1992). Increased cardiac awareness in panic disorder. J
  36. Abnorm Psychol, 140: 164-172.
  37. Ehlers A. (1993). Interoception and panic disorder. Advance of Behav Res Ther, 15: 3-21.
  38. Ehlers A., Margraf J., Roth W.T., Taylor C.B., Birbaumer N. (1988a). Anxiety
  39. induced by false heart rate feedback in patients with panic disorder. Behav Res Ther, 26: 1-11.
  40. Ehlers A., Margraf J., Roth W.T. (1988b). Selective information processing, interoception, and panic attacks. In: Hand I., Wittchen H.U. (Eds.). Panic and phobias 2 (pp. 129-148). Berlin: Springer-Verlag.
  41. Faravelli C.,Webb T., Ambonetti A., Fonnesu F., Sessarego A. (1985). Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks. Am J Psychiatry, 142: 1493-1494.
  42. Farber G.A., Levin T., White C.A. (2005). A cognitive therapy conceptualization of panic disorder exacerbated by interferon treatment. Gen Hosp Psychiatry, Sep-Oct, 27(5): 329-37.
  43. Freire R.C., Machado S., Arias-Carrión O., Nardi A.E. (2014). Current pharmacological interventions in panic disorder. CNS Neurol Disord Drug Targets, 13(6): 1057-1065.
  44. Freire R.C., Zugliani M.M., Garcia R.F., Nardi A.E. (2016). Treatment-resistant
  45. panic disorder: a systematic review. Expert Opin Pharmacother, 17(2): 159-168.
  46. Freud S. (1950). The justification for detaching from neurasthenia a particular
  47. syndrome: the anxiety neurosis (1894). Collected papers, vol. 1. London: Hogart Press, pp. 76-127.
  48. Furukawa T.A., Watanabe N., Churchill R. (2007). Combined psychotherapy
  49. plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev, 24(1): CD004364.
  50. Gadermann A.M., Alonso J., Vilagut G., Zaslavsky A.M., Kessler R.C. (2012).
  51. Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depress Anxiety, 29: 797-806.
  52. Galderisi S., Mancuso F., Mucci A., Garramone S., Zamboli R., Maj M. (2008). Alexithymia and cognitive dysfunctions in patients with panic disorder. Psychother Psychosom, 77(3): 182-188.
  53. Gigante M., Presta A. (1962). PAN. Antologia della letteratura greca. Messina: D’Anna.
  54. Gittelman Klein R. (1997). Separation Anxiety and Adult Anxiety Disorders. Giorn Ital Psicopat, 1: 4-10.
  55. Goodwin R.D., Fergusson D.M., Horwood L.J. (2005). Childhood abuse and familial violence and the risk of panic attacks and panic disorder in young adulthood. Psychol Med, 35: 881-890.
  56. Goodwin R.D., Stein D.J. (2013). Anxiety disorders and drug dependence: evidence on sequence and specificity among adults. Psychiatry Clin Neurosci., 67(3): 167-173.
  57. Grant B.F., Saha T.D., Ruan W.J., Goldstein R.B., Chou S.P., Jung J., Zhang H.,
  58. Smith S.M., Pickering R.P., Huang B., Hasin D.S. (2016). Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry, 73(1): 39-47.
  59. Grant B.F., Goldstein R.B., Saha T.D., Chou S.P., Jung J., Zhang H., Pickering
  60. R.P., Ruan W.J., Smith S.M., Huang B., Hasin D.S. (2015). Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8): 757-66.
  61. Gravielle M.C. (2016). Activation-induced regulation of GABAA receptors: Is
  62. there a link with the molecular basis of benzodiazepine tolerance? Pharmacol Res, 109: 92-100.
  63. Guidano V. (2007). Psicoterapia cognitiva post-razionalista. Una ricognizione della teoria alla clinica. Milano: FrancoAngeli.
  64. Hillman J. (1977). Saggio su Pan. Milano: Adelphi.
  65. Hope J.A. (1832). A Treatise on the Disease of the Heart and Great Vessels
  66. Comprising a New View of the Physiology of the Heart’s Action. According to Which the Physical Signs are Explained. London: Churchill.
  67. Hosoda S., Takimura H., Shibayama M., Kanamura H., Ikeda K., Kumada H. (2000). Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci, 54(5): 565-72.
  68. Izci F., Gültekin B.K., Saglam S., Koc M.I., Zincir S.B., Atmaca M. (2014). Temperament, character traits, and alexithymia in patients with panic disorder. Neuropsychiatr Dis Treat, 16(10): 879-85.
  69. Johnson P.L., Federici L.M., Shekhar A. (2014). Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neurosci Biobehav Rev, 46(3): 429-454.
  70. Kagan J., Reznick J.S., Snidman N. (1993). Biological bases of childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry, 1: 2-16.
  71. Kaplan H.I., Sadock B.J., Grebb J.A. (1996). Psichiatria: manuale di scienze del comportamento e psichiatria clinica. Torino: Centro Scientifico Internazionale.
  72. Katzman M.A., Bleau P., Blier P., Chokka P., Kjernisted K., Van Ameringen M., Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony M.M., Bouchard S., Brunet A., Flament M., Grigoriadis S., Mendlowitz S., O’Connor K., Rabheru K., Richter P.M., Robichaud M., Walker J.R. (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry, 14(Suppl 1): S1.
  73. Keefe R.S.E. (1995). The contribution of neuropsychology to psychiatry. Am J
  74. Psychiatry, 152: 6-15.
  75. Kessler R.C., Davis C.G., Kendler K.S. (1997). Childhood adversity and adult
  76. psychiatric disorder in the US National Comorbidity Survey. Psychol Med, 27: 1101-1119.
  77. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. (2005). Lifetime prevalence and ageof-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 62: 593-602.
  78. Kessler R.C., Chiu W.T., Jin R., Ruscio A.M., Shear K., Walters E.E. (2006). The
  79. epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 63(4): 415-424.
  80. Klauke B., Deckert J., Reif A., Pauli P., Domschke K. (2010). Life events in panic disorder-an update on “candidate stressors”. Depress Anxiety, 27(8): 716-730.
  81. Klein D.F. (1964). Delineation of two drug-responsive syndromes. Psychopharmacologia, 53: 397-408.
  82. Klein R.G. (1995). Is panic disorder associated with childhood separation anxiety disorder? Clin Neuropharmacol, 18(Suppl 2): 7-14.
  83. Kobak R.R., Sceery A. (1988). Attachment in late adolescence: working models, affect regulation, and representation of self and others. Child Dev, 59: 135-46.
  84. Kosiba J.D., Gonzalez A., O’Cleirigh C., Safren S.A. (2014). Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence. Cognit Ther Res, 38(4): 458-464.
  85. Kossowsky J., Pfaltz M.C., Schneider S., Taeymans J., Locher C., Gaab J. (2013). The separation anxiety hypothesis of panic disorder revisited: a meta-analysis. Am J Psychiatry, 170(7): 768-781.
  86. Koszycki D., Taljaard M., Segal Z., Bradwejn J. (2011). A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder. Psychol Med, 41(2): 373-383.
  87. Krystal H., Raskin H. (1970). Drug dependence: aspects of ego function. Detroit, MI: Wayne State University Press.
  88. Kolb B., Whishaw I.Q. (1990). Fundamentals of human neuropsychology, 3rd ed. New York: Freeman.
  89. Kroenke K. (2003). Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res, 12: 34-43.
  90. Lader M. (2011). Benzodiazepines revisited-will we ever learn? Addiction, 106(12): 2086-2109.
  91. Lalive A.L., Rudolph U., Lüscher C., Tan K.R. (2011). Is there a way to curb
  92. benzodiazepine addiction? Swiss Med Wkly, (19): 141, w13277.
  93. Lane R.D., Schwartz G.E. (1987). Levels of emotional awareness: a cognitive
  94. developmental theory and its application to psychopathology. Am J Psychiatry, 144: 133-143.
  95. Lane R.D., Sechrest L., Reidel R.G., Weldon V., Kaszniak A.W., Schwartz G.E.
  96. (1996). Impaired verbal and non verbal emotion recognition in alexithymia. Psychosom Med, 58: 203-210.
  97. Lane R.D., Ahern G.L., Schwartz G.E., Kaszniak A.W. (1997). Is alexithymia
  98. the emotional equivalent of blindsight? Biol Psychiatry, 42: 834-844.
  99. Maj M. (2014). Introduzione all’edizione italiana. In: Manuale diagnostico e
  100. statistico dei disturbi mentali - Quinta edizione (DSM-5). American Psychiatric Association. Milano: Raffaello Cortina.
  101. Marchesi C., Brusamonti E., Borghi C., Giannini A., Di Ruvo R., Minneo F., Quarantelli C., Maggini C. (2004). Anxiety and depressive disorders in an emergency generalised anxiety disorders in the general adult population: a
  102. systematic review of cohort studies. J Affect Disord, 168: 337-348.
  103. National Collaborating Centre for Mental Health, National Collaborating Centre for Primary Care (2011). Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care. London: National Institute for Health and Clinical Excellence (NICE).
  104. Nardi A.E., Freire R.C., Mochcovitch M.D., Amrein R., Levitan M.N., King A.L., Valença A.M., Veras A.B., Paes F., Sardinha A., Nascimento I., de-Melo-Neto V.L., Dias G.P., E Silva A.C., Soares-Filho G.L., da Costa R.T., Mezzasalma M.A., de Carvalho M.R., de Cerqueira A.C., Hallak J.E., Crippa J.A., Versiani M. (2012). A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol, 32: 120-126.
  105. Nemiah J.C., Freyberger H., Sifneos P.E. (1976). Alexithymia: A view of the psychosomatic process. In: Hill O.W. Modern Trends in Psychosomatic Medicine, vol. 3 (pp. 430-439). London: Butterworths.
  106. Nemiah J.C., Sifneos P.E. (1970). Affect and fantasy in patients with psychosomatic disorders. In: Hill O.W. (Ed.). Modern Trends in Psychosomatic Medicine, vol. 2 (pp. 26-34). London: Butterworths.
  107. Nemiah J.C. (1984a). Anxiety and psychodynamic theory. In: Grinspoon L. (Ed.). Psychiatry Update: The American Psychiatric Annual Review, vol. 3 (pp. 426-440). Washington, DC: American Psychiatric Press.
  108. Nemiah J.C. (1984b). The psychodynamic view of anxiety. In: Pasnau R.O. (Ed.). Diagnosis and treatment of anxiety disorder. Washington, DC: American Psychiatric Press.
  109. O’Brien C.P., Volkow N., Li T.-K. (2006). What’s in a word? Addiction versus
  110. dependence in DSMV. Am J Psychiatry, 163: 764-765.
  111. Parker J.D.A., Taylor G.J., Bagby R.M., Acklin M.W. (1993). Alexithymia in panic disorder and simple phobia: a comparative study. Am J Psychiatry, 150: 1105-1107.
  112. Pauli P., Marquardt C., Hartl L., Nutzinger D.O., Holzl R., Strian F. (1991). Anxiety induced by cardiac perceptions in patients with panic attacks: a field study. Behav Res Ther, 29: 137-45.
  113. Perna G., Guerriero G., Brambilla P., Caldirola D. (2014). Panic and the brainstem: clues from neuroimaging studies. CNS Neurol Disord Drug Targets, 13(6): 1049-56.
  114. Perna G., Guerriero G., Caldirola D. (2011). Emerging drugs for panic disorder. Expert Opin. Emerg Drugs, 16: 631-645.
  115. Perna G., Alciati A., Balletta R., Mingotto E., Diaferia G., Cavedini P., Nobile M., Caldirola D. (2016). Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines. Int J Mol Sci, 13: 17(4).
  116. Peter H., Bruckner E., Hand I., Rufer M. Childhood (2005). Separation anxiety and separation events in women with agoraphobia with or without panic disorder. Can J Psychiatry, 50: 941-944.
  117. Pompoli A., Furukawa T.A., Imai H., Tajika A., Efthimiou O., Salanti G. (2016). Psychological therapies for panic disorder with or without agoraphobia in adults:a network meta-analysis. Cochrane Database Syst Rev, 13(4): D011004.
  118. Preter M., Klein D.F. (2014). Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorder. Neurosci Biobehav Rev, 46(3): 345-351.
  119. Pribor E.F., Dinwiddie S.H. (1992). Psychiatric correlates of incest in childhood. Am J Psychiatry, 149: 52-56.
  120. Raphael B. (1983). The anatomy of bereavement. New York: Basic Books.
  121. Reed G.M., Mendonça Correia J., Esparza P., Saxena S., Maj M. (2011). The
  122. WPA-WHO Global Survey of Psychiatrists’ Attitudes Towards Mental Disorders Classification. World Psychiatry, 10(2):118-131.
  123. Rosenbaum J.F., Biederman J., Bolduc-Murphy E.A., Faraone S.V., Chaloff J.,
  124. Hirshfeld D.R., Kagan J. (1993). Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry, 1: 2-16.
  125. Royal Australia and New Zealand College of Psychiatrists (2003). Australian
  126. and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry, 37: 641-656.
  127. Sacks S., Chaple M., Sirikantraporn J., Sacks J.Y., Knickman J., Martinez J. (2013). Improving the capability to provide integrated mental health and substance abuse services in a state system of outpatient care. J Subst Abuse Treat, 44: 488-493.
  128. Sacks S., McKendrick K., Sacks J.Y., Cleland C.M. (2010). Modified therapeutic community for co-occurring disorders: single investigator meta analysis. Subst Abus, 31: 146-161.
  129. Sacks S., McKendrick K., Sacks J.Y., Banks S., Harle M. (2008). Enhanced outpatient treatment for co-occurring disorders: main outcomes. J Subst Abuse Treat, 34: 48-60.
  130. Salzman C. (1991). The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry, 148: 151-2.
  131. Salovey P., Mayer J.D. (1990). Emotional intelligence. Imagination, Cognition
  132. and Personality, 9: 185-211.
  133. Santos M., D’Amico D., Dierssen M. (2015). From neural to genetic substrates of panic disorder: Insights from human and mouse studies. Eur J Pharmacol, 759: 127-141.
  134. Shaffer H.J. (1999). Strange bedfellows: a critical view of pathological gambling and addiction. Addiction, 94(10): 1445-1448.
  135. Sifneos P.E. (1972). Short-Term Psychotherapy and Emotional Crisis. Cambridge. MA: Harvard University Press.
  136. Sifneos P.E. (1988). Alexithymia and its relationship to hemispheric specialization, affect, and creativity. Psychiatric Clinics of North America, 11: 287-292.
  137. Soumerai S.B., Simoni-Wastila L., Singer C., et al. (2003). Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatr Services, 54: 1006-1011.
  138. Sroufe L.A. (1983). Infant-caregiver attachment in the pre-school: the roots of
  139. competence and maladaptation. In: Perlmutter M. (Ed.). Development and policy concerning children with special needs. Hove: Lawrence Erlbaum Associated.
  140. Starcevic V. (2016). The importance of distinguishing between dependence and
  141. addiction in the context of long-term benzodiazepine use. Aust N Z J Psychiatry, Apr 18, pii: 0004867416644980.
  142. Starcevic V. (2014). The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Expert Rev Neurother., 14(11): 1275-1286.
  143. Starcevic V. (2012). Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks. Advances in psychiatric treatment, 18: 250-258.
  144. Taylor G.J., Bagby R.M., Parker J.D.A. (1991). The alexithymia construct; apotential paradigm for psychosomatic medicine. Psychosomatics, 32: 153-164.
  145. Taylor G.J. (1992a). Psychoanalysis and psychosomatics: a new synthesis. J
  146. Am Acad Psychoanal, 20: 251-275.
  147. Taylor G.J. (1992b). The alexithymia construct: conceptualization, validation,
  148. and relationship with basic dimensions of personality. International Workshop on Alexithymia, 4th National Congress of the Italian Society of Medical Psychology. Pavia.
  149. Taylor G.J. (2010). Affects, trauma, and mechanisms of symptom formation:
  150. a tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom, 79(6): 339-349.
  151. Troisi A., D’argenio A., Peracchio F., Petti P. (2001). Insicure attachment and
  152. alexithymia in young men with mood symptoms. J Nerv Ment Dis, 189: 311-316.
  153. Tsao J.C., Dobalian A., Naliboff B.D. (2004). Panic disorder and pain in a national sample of persons living with HIV. Pain, 109: 172-180.
  154. Tuescher O., Protopopescu X., Pan H. et al. (2011). Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD. J Anxiety Disord, 25(2): 251-257.
  155. Uzun S., Kozumplik O., Jakovljeviç M., Sediç B. (2010). Side effects of treatment with benzodiazepines. Psychiatr Danub, 22(1): 90-93.
  156. Van Apeldoorn F.J., Van Hout W.J., Timmerman M.E., Mersch P.P., den Boer J.A. (2013). Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined. J Affect Disord., 150(2): 313-319.
  157. Van Apeldoorn F.J., Timmerman M.E., Mersch P.P.A., van Hout W.J., Visser S., van Dyck R., den Boer J.A. (2010). A randomized trial of cognitivebehavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: Treatment results through 1-year follow-up. J Clin Psychiatry, 71: 574-586.
  158. Westphal C. (1872). Die Agoraphobie: eine neuropathische Erscheinung. Arkhivder Psychiatrie, 3: 138-161.
  159. World Health Organization (1979). Manual of the International Classification of Diseases, Injuries, and Causes of Death, 9th revision – Clinical Modification. Commission on Professional and Hospital Activities. Mich.: Ann Arbor. Versione italiana: www.salute.gov.it/imgs/C_17_pubblicazioni_2251_allegato.pdf.
  160. World Health Organization (1992). International Classification of Diseases: Clinical Descriptions and Diagnostic Guidelines, 10th revision. Geneva: WHO.
  161. Zeitlin S.B., McNally R.J. (1993). Alexithymia and anxiety sensitivity in panic disorder and obsessive-compulsive disorder. Am J Psychiatry, 150(4): 658-60.
  162. Zou Z., Huang Y., Wang J., He Y., Min W., Chen X., Wang J., Zhou B. (2016).
  163. Association of childhood trauma and panic symptom severity in panic disorder: Exploring the mediating role of alexithymia. J Affect Disord, 21(206): 133-139.
  164. Zvolensky M.J., Bernstein A., Marshall E.C., Feldner M.T. (2006). Panic attacks, panic disorder, and agoraphobia: associations with substance use, abuse, and dependence. Curr Psychiatry Rep, 8: 279-285.

Metrics

Metrics Loading ...